EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PTPN2 Regulates Iron Handling Protein Expression in Inflammatory Bowel Disease Patients and Prevents Iron Deficiency in Mice

Hillmin Lei iD, Ali Shawki, Alina N Santos, Vinicius Canale iD, Salomon Manz iD, Meli'sa S Crawford iD, Pritha Chatterjee, Marianne R Spalinger iD, Michael Scharl, Declan F McCole iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26073356 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Hillmin Lei und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Division of Biomedical Sciences, University of California, Riverside, CA 92521, USA. Hauptthemen laut MEDLINE: Protein Tyrosine Phosphatase, Non-Receptor Type 2, Iron, Inflammatory Bowel Diseases, Anemia, Iron-Deficiency. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation Advanced Postdoctoral Mobility Grant, NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anemia is the most common extraintestinal manifestation of inflammatory bowel disease (IBD). Iron deficiency is the most frequent cause of anemia in IBD; however, the mechanisms involved are still poorly understood. Here, we investigated the role of the IBD risk gene, protein tyrosine phosphatase non-receptor type 2 (PTPN2), in regulating iron homeostasis. Proteomic analyses were performed on serum from IBD patients genotyped for the IBD-associated loss-of-function rs1893217 PTPN2 variant. Constitutive Ptpn2 wild type (WT), heterozygous (Het), and knockout (KO) mice were analyzed for iron content, blood parameters, and expression of iron handling proteins. Iron absorption was assessed through radiotracer assays. Serum proteomic analyses revealed that the “iron homeostasis signaling pathway” was the main pathway downregulated in Crohn’s disease (CD) patients carrying the PTPN2 risk allele, independent of disease activity. Ptpn2-KO mice showed characteristics of anemia, including reduced hemoglobin concentrations along with serum and tissue iron deficiency and elevated serum hepcidin levels vs. Ptpn2-WT and Het mice. 55Fe absorption via oral gavage was significantly impaired in Ptpn2-KO mice. Correspondingly, Ptpn2-KO mice showed reduced apical membrane expression of the iron transporter DMT1. CD patients with the PTPN2 loss-of-function rs1893217 variant display alterations in serum iron handling proteins. Loss of Ptpn2 in mice caused features of anemia, including iron deficiency associated with reduced apical membrane expression of DMT1. These findings identify an important role for PTPN2 in regulating systemic iron homeostasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Tyrosine Phosphatase, Non-Receptor Type 2IronInflammatory Bowel DiseasesAnemia, Iron-DeficiencyIron DeficienciesAnimalsMiceMice, KnockoutHumansMaleFemaleProteomicsMice, Inbred C57BLCation Transport ProteinsAdultDisease Models, AnimalHomeostasisSolute Carrier Family 11, Member 2

Stichwörter der Autor:innen

anemiainflammatory bowel diseaseiron deficiency

Substanzen

Protein Tyrosine Phosphatase, Non-Receptor Type 2IronCation Transport ProteinsSolute Carrier Family 11, Member 2PTPN2 protein, humanPtpn2 protein, mouse

Autor:innen und Institutionen

  • School of Medicine, Division of Biomedical Sciences, University of California, Riverside, CA 92521, USA.
  • Department of Gastroenterology & Hepatology, University Hospital Zurich, 8091 Zurich, Switzerland.

ORCID-Profile: Hillmin Lei, Vinicius Canale, Salomon Manz, Meli'sa S Crawford, Marianne R Spalinger, Declan F McCole

Förderung

  • Swiss National Science Foundation Advanced Postdoctoral Mobility Grant
  • NIH HHS
  • NIDDK NIH HHS
  • NIAID NIH HHS
  • NIH/NIAID
  • UCR-City of Hope CUBRI Award
  • NIH

Zitieren

APA

Lei, H., Shawki, A., Santos, A. N., Canale, V., Manz, S., Crawford, M. S., Chatterjee, P., Spalinger, M. R., Scharl, M., & McCole, D. F. (2025). PTPN2 Regulates Iron Handling Protein Expression in Inflammatory Bowel Disease Patients and Prevents Iron Deficiency in Mice. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26073356

Vancouver

Lei H, Shawki A, Santos AN, Canale V, Manz S, Crawford MS, et al. PTPN2 Regulates Iron Handling Protein Expression in Inflammatory Bowel Disease Patients and Prevents Iron Deficiency in Mice. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26073356

BibTeX
@article{Lei2025,
  author = {Lei, Hillmin and Shawki, Ali and Santos, Alina N and Canale, Vinicius and Manz, Salomon and Crawford, Meli'sa S and Chatterjee, Pritha and Spalinger, Marianne R and Scharl, Michael and McCole, Declan F},
  title = {PTPN2 Regulates Iron Handling Protein Expression in Inflammatory Bowel Disease Patients and Prevents Iron Deficiency in Mice},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26073356}
}
Kostenlos starten →